QuidelOrtho to Report Third Quarter 2026 Financial Results on November 3, 2026
QuidelOrtho (Nasdaq: QDEL) will report its third-quarter 2026 financial results after the market closes on November 3, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
QuidelOrtho (Nasdaq: QDEL) will report its third-quarter 2026 financial results after the market closes on November 3, 2026. The quarter ended September 27, 2026. A conference call and webcast will follow at 5:00 p.m. ET / 2:00 p.m. PT, with a replay available afterward on the company's website.
Key Figures
- Results reporting date
- November 3, 2026
- Third-quarter 2026 financial results scheduled after market close
AI-generated analysis. How Rhea-AI works. Not financial advice.
Following the release, QuidelOrtho will hold a conference call and webcast beginning at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial results. Interested parties can access the live webcast on the "Investor Relations" page of the Company's website at https://ir.quidelortho.com/events-and-presentations. A replay of the webcast will be available shortly after the event on the Company's website.
QuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit quidelortho.com and follow QuidelOrtho on LinkedIn, Facebook and X.
About QuidelOrtho Corporation
With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation (Nasdaq: QDEL) is a leading global provider of diagnostic solutions, dedicated to advancing fast, accurate and reliable results that help improve patient outcomes – from the point of care to hospital, lab to clinic. Building on a legacy of innovation, QuidelOrtho works with healthcare providers to advance diagnostics that connect insights with solutions, defining a clearer path for informed decisions and better care.
Investor Contact:
Sanjeev Sharma
Vice President, Investor Relations
IR@QuidelOrtho.com
Media Contact:
Stephanie Kleewein
Senior Corporate Communications and PR Manager
media@QuidelOrtho.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/quidelortho-to-report-third-quarter-2026-financial-results-on-november-3-2026-302908607.html
SOURCE QuidelOrtho Corporation